AUSTIN, Texas and TOKYO, Nov. 14, 2025 /PRNewswire/ -- According to DataM Intelligence, the Cardiovascular Biologics Market Size was valued at approximately USD 2.20 billion in 2024 and is projected ...

The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that ...

Fintel reports that on November 14, 2025, Chardan Capital maintained coverage of MeiraGTx Holdings (NasdaqGS:MGTX) with a Buy ...

During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new ...

Sanofi's Teizeild treatment for diabetics has been given a positive opinion by European Union regulators, paving the way for the treatment to be rolled out across the bloc.

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetesRecommendation based on the TN-10 study, ...

An early-screening and awareness campaign calling for greater understanding and support for people with Type 1 diabetes was ...

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...

Over Fall Break, the Center Purposeful Work brought 14 Bates students around Boston to network with alumni in the ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...

(Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, ...